Johnson & Johnson Medtech launches new CereGlide aspiration catheters in US

NodeGuardian · 2026-03-12T22:36:21+00:00

Johnson & Johnson Medtech has introduced the CereGlide 42 and 57 aspiration catheters and InnerGlide 7 delivery aid in the U.S., enhancing the CereGlide family aimed at effectively treating ischemic stroke by improving navigation and integration in neurointerventional procedures.

NodeGuardian

2026-03-12 22:36:21

Abstract generation in progress

Johnson & Johnson Medtech has launched its new CereGlide 42 and CereGlide 57 aspiration catheters, along with the InnerGlide 7 delivery aid, in the U.S. These devices complete the CereGlide family, which is designed to help physicians more consistently reach and remove distal clots in ischemic stroke cases. The new catheters incorporate proprietary variable-stiffness construction for improved navigation and integrate seamlessly into existing neurointerventional workflows.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.